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Abstract
Introduction. There were many clinical practice guidelines (CPG) intraabdominal infection/complicated intraabdominal infections (cIAI) have
been developed since 1992 and were periodically updated recently. But to date, the implementation in Indonesia encountering problems. One is
Indonesian characteristics which is differed to the population of where the CPG developed. To adapt a CPG, the quality of CPG should be first
critically appraised. The best will be used furthers as the subject to be adapted, with modification regarding Indonesian characteristics.
Method. A literature search carried out on guidelines databases to find out CPG on cIAI (1992–2017). The assessment preceded using AGREE
II tools (MyAGREE platform) focused on 23 assessments in 6 domains (scope and purpose, stakeholder involvement, rigour of development,
clarity of presentation, applicability, and editorial independence). Such an assessment placed a guideline in rating of 1 to 7. Updated guidelines
were assessed using Checklist for the Reporting of Updated Guidelines (CheckUp). Appraised CPG were discussed.
Results. There were 33 CPG in full text downloaded and subjected to selection criteria. Duplicates and those irrelevant were excluded. In the
assessment there were 18 CPG included and 13 guidelines places the strong recommended category, two can be recommended and other 2 were
not recommended. All updated CPG met the criteria of the best quality updates.
Conclusion. Two cIAI–CPG were met the criteria of the quality guidelines to be adopted. These guidelines were developed in accordance with
appropriateness in development a CPG and were updated.
Keywords: cIAI guidelines, AGREE II, CheckUp

Introduction
There were guidelines intraabdominal infection/complicated
intraabdominal infections have been developed since 1992 to
reduce mortality of those who suffered cIAIs. These guidelines, as
the rules, were updated periodically where the last updated in 2017.
Though it had been developed for years, its implementation in
Indonesian surgeons almost nil, whereas De Simone and colleagues
showed in a review that an inexpensive and easily application of
guidelines based on medicine evidence in the use of antibiotics can
lead to a significative reduction of hospital costs with outcomes
improvement.1 There were explanatory reasons proposed. Firstly,
Indonesian characteristics of which is differed to the population in
centers of where those guidelines developed. This issue is a reason
of why the guideline couldn’t be implemented by many surgeons.
Secondly, a guideline should be critically appraised prior to
endorsing its recommendations to reduce unnecessary variations in
care.2 Guidelines are also meant to eliminate unnecessary and
unjustified variations in practice, but their efficacy in that regard is
debatable. Naturally, clinical guidelines cannot be applied to
eradicate variations because an enormous number of variables —
for example, local characteristics and comorbid conditions —
influencing clinical decisions. Guidelines may consider variations in
clinical settings, resources, and other variables, but may not always
adjust for the combination of resources that may be available to a
physician. In addition, it would be unwise, even if it were possible,
to provide completely uniform care because some variations, such
as those that result from an individual physician's professional
judgment, are universally acceptable.2

Therefore, despite providing Indonesian epidemiology of
microorganisms related to cIAIs which is Indonesian specific, we
run an appraisal to published guidelines from 1992 to 2017 to find
out the best and suitable for Indonesian. These will be of benefit to
adapt the best one, with modification to Indonesian characteristics.
Method
Guidelines search preceded on all available guidelines database
sites: Ärztliches Zentrum für Qualität in der Medizin (AEZQ,
German Agency for Quality in Medicine), Guidelines Advisory
Committee (GAC, Canada), Guidelines International Network
(GIN), Grading of Recommendations Assessment, Development
and Evaluation (GRADE), Haute Autorité de Santé (HAS, France),
Institute for Clinical Systems Improvement (ICSI), National
Guideline Clearinghouse (NGC), National Institute for Health and
Care Excellence (NICE), New Zealand Guidelines Group (NZGC),
and publishers (BioMed central, ClinicalKey, EBSCOhost,
Embase–Elsevier, Liebertpub, Oxford, ProQuest, PubMed,
ScienceDirect, Springer, etc.). The keywords used was: ‘cliinical
practice guidelines”, AND “intraabdominal infections”, OR “IAIs”,
AND “complicated intraabdominal infections”, OR “cIAIs”. All
CPGs about IAIs and cIAIs. These CPGs were screened out for
duplicates and those where the full text available were included to
the appraisal. The appraisal carried out using AGREE II Tools (My
AGREE
PLUS
platform,
available
online,
www.agreetrust.org/agree-ii/) rating 23 assessments (1 to 7) in six
domains, i.e. scope and purpose, stakeholder involvement, rigour of
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development, clarity of presentation, applicability, and editorial
independence. Overall quality of guidelines was analyzed, where
the criteria of the best was those with the greater scores. The updates
were also subjected to appraisal in accordance with Checklist for the
Reporting of Updated Guidelines (CheckUp)3 The assessment was
carried out independently by experts. There were sixteen
assessments in the CheckUp as follows. 1) The updated version can
be distinguished from the previous version of the clinical guideline,
2) The rationale for updating the clinical guideline is reported, 3)
Changes in the scope and purpose between the updated and
previous version are described and justified, 4) The sections
reviewed in the updating process are described, 5)
Recommendations are clearly presented and labelled as new,
modified, or not changed. Deleted recommendations are clearly
noted, 6) Changes in recommendations are reported and justified, 7)
The panel participants in the updated version are described, 8)
Disclosures of interests of the group responsible for the updated
version are recorded, 9) The role of the funding body for the updated
version is identified and described, 10) The methods used for
searching and identifying new evidence in the updating process are
described, 11) The methods used for evidence selection in the
updating process are described, 12) The methods used to assess the
quality of the included evidence in the updating process are
described, 13) The methods used for the evidence synthesis in the
updating process are described, 14) The methods used for externally
reviewing the updated version are described and 15) The methods
and plan for implementing the changes of the updated version in
practice are described, and 16) The plan and methods for updating
the new version in the future are reported. In contrast to scoring
applied in AGREE II tools to find out the best one, the criteria as the
best was those with score of 16 (where one represent score for each
assessment).
The recommendation of such a CPGs based on the criteria in
AGREE user manual 2001 (revised on 2013),4 applied by Gorman
in his appraising CPGs on pharmacotherapy5 stated that a guideline
can be strongly recommended if the majority of item scores are 3 or
4 and the majority of standardized domain scores are 60% or
greater. A guideline can be recommended with alterations if there

are equal numbers of item scores 3 or 4 and 1 or 2, and most
standardized domain scores are between 30 and 60%. A guideline
cannot be recommended if majority of item scores are 1 or 2, and
most standardized domain scores are 30% or less.5

Results

On literature search, there were 68 guidelines available in those
databases and downloaded. On the first selection, there were 33
cIAIs related–guidelines included. On the second selection, there
were thirteen cIAIs–CPGs and five IAIs–CPGS enrolled in the
assessment. Out of these, the majority of cIAIs guidelines developed
by Infectious Diseases Society of America (IDSA) and World
Society of Emergency Surgery (WSES). There were also CPGs
developed by Canadian Surgical Society (CSS) and Canadian
Association of Medical Microbiology and Infectious Disease
(AMMI), France, Spanish, Turkish, and Asian developed a single
guideline each. Other related guidelines developed were, Tokyo
guidelines in the management for cholangitis and cholecystitis;
European Association for the Study of the Liver (EASL) guidelines
for primary biliary cholangitis, and Japanese Society for Abdominal
Emergency Medicine guideline for acute abdomen. Most
guidelines were focused on the management, whereas 4 were
focused on antibiotics; it was noticed five guidelines were the
updated CPGs (see table 1for detail).
On the first step of assessment using AGREE II tools, mostly total
scores were >60% (see table 1 for detail); only a few items were
scores under 30%. In accordance with AGREE scoring, those with
the majority (>4) items scores were greater than 60% were set as
strongly recommended (see table 2). The next step was to appraise
for updating. For this purpose, following assessment it found that all
updates were having a same score, which was 20 (see table 3).
Thus, those of the two latest CPGs were recommended to be
adopted.

Figure 1. Literature search, selection, and appraising
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Table 1. Critical appraisal of IAIs (cIAIs) CPGs using AGREE II Tools
Author(s)

Year

1

Mazuski, et al

2002

2

Solomkin, et al

2003

3

Chow, et al

2010

4

Solomkin, et al

2010

5

Eckman, 2011

2011

6

Sartelli, et al

2011

7

Sartelli, et al

2013

8

Yamashita, et al

2013

9

Kurup, et al

2014

10

Montravers, et al

2015

11

Vildan, et al

2016

12

Di Saviero, et al

2016

13

Ansaloni, et al

2016

14

Sartelli, et al

2016

15

Mazuski, et al

2017

16

Sartelli, et al

2017

Guidelines
The Surgical Infection Society Guidelines on
Antimicrobial Therapy for Intra-Abdominal Infections:
Evidence for the Recommendations
Guidelines for the Selection of Anti-infective Agents for
Complicated Intra-Abdominal Infections
Canadian practice guidelines for surgical intraabdominal infections
Diagnosis and Management of Complicated IntraAbdominal Infections in Adults and Children:
Guidelines by the Surgical Infection Society and the
Infectious Diseases Society of America
Antimicrobial
Treatment
of
Complicated
Intraabdominal Infections and The New IDSA
Guidelines - A Commentary and An Alternative
European Approach According to Clinical Definitions
WSES consensus conference: Guidelines for first line
management of intraabdominal infections
2013 WSES guidelines for management of intraabdominal infections
TG13 surgical management of acute cholecystitis
Antibiotic management of complicated intra-abdominal
infections in adults: The Asian perspective
Guidelines for management of intra-abdominal
infections
Recommendations for intra-abdominal infections
consensus report
WSES Jerusalem guidelines for diagnosis and treatment
of acute appendicitis
2016 WSES guidelines on acute calculous cholecystitis
WSES Guidelines for the management of acute left sided
colonic diverticulitis in the emergency setting
The Surgical Infection Society Revised Guidelines on
the Management of Intra-Abdominal Infections
Management
of
intra-abdominal
infections:
recommendations by the WSES 2016 consensus
conference

Scope and
Purpose

Stakeholder
Involvement

Rigour of
Development

Clarity of
Presentation

Applicability

Editorial
Independence

96.6%

90%

29%

100%

35%

27%

100%

100%

77.1%

76%

27%

54.5%

83.3%

76.6%

93.8%

100%

62.5%

54.5%

90%

76.6%

73.5%

96.6%

81.3%

54.5%

56.6%

63.3%

49%

43.3%

18.8%

54.5%

36.6%

86.6%

65.6%

86.6%

50%

54.5%

93.3%

83.3%

60.4%

96%

72.4%

54.5%

93.3%

100%

48%

80%

56.3%

41%

70%

63%

15.6%

10%

14.5%

54.5%

100%

93.3%

83.3%

100%

79.2%

54.5%

100%

100%

88.5%

80%

83.3%

54.5%

93.3%

90%

69.8%

66.6%

48%

54.5%

83.3%

96.6%

74%

90%

62.5%

54.5%

70%

90%

54.2%

80%

50%

54.5%

86%

100%

90.6%

100%

89.5%

54.5%

93.3%

76.6%

92.7%

93.3%

52%

54.5%
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Table 2. Critical appraisal of IAIs (cIAIs) CPGs using AGREE II Tools (cont.)
Author(s)

Year

17

Sartelli, et al

2017

18

Hirschﬁeld, et al

2017

Guidelines
The management of intra-abdominal infections from a
global perspective: 2017 WSES guidelines for
management of intra-abdominal infections
EASL Clinical Practice Guidelines: The diagnosis and
management
of patients with primary biliary cholangitis

Scope and
Purpose

Stakeholder
Involvement

Rigour of
Development

Clarity of
Presentation

Applicability

Editorial
Independence

100%

100%

80.2%

73.8%

87.5%

54.5%

100%

100%

100%

93.3%

92%

54.5%

Table 2. Critical appraisal of IAIs (cIAIs) CPGs using AGREE II Tools
Clinical practice guidelines

Critically appraised

1
2

Mazuski, et al
Solomkin, et al

2002
2003

The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: Evidence for the Recommendations
Guidelines for the Selection of Anti-infective Agents for Complicated Intra-Abdominal Infections

Can be recommended
Can be recommended

3

Chow, et al

2010

Strongly recommended

4

Solomkin, et al

2010

5

Eckman, 2011

2011

6
7
8
9
10
11
12
13
14

Sartelli, et al
Sartelli, et al
Yamashita, et al
Kurup, et al
Montravers, et al
Vildan, et al
Di Saviero, et al
Ansaloni, et al
Sartelli, et al

2011
2013
2013
2014
2015
2016
2016
2016
2016

Canadian practice guidelines for surgical intra-abdominal infections
Diagnosis and Management of Complicated Intra-Abdominal Infections in Adults and Children: Guidelines by the Surgical Infection Society
and the Infectious Diseases Society of America
Antimicrobial Treatment of Complicated Intraabdominal Infections and The New IDSA Guidelines - A Commentary and An Alternative
European Approach According to Clinical Definitions
WSES consensus conference: Guidelines for first line management of intraabdominal infections
2013 WSES guidelines for management of intra-abdominal infections
TG13 surgical management of acute cholecystitis
Antibiotic management of complicated intra-abdominal infections in adults: The Asian perspective
Guidelines for management of intra-abdominal infections
Recommendations for intra-abdominal infections consensus report
WSES Jerusalem guidelines for diagnosis and treatment of acute appendicitis
2016 WSES guidelines on acute calculous cholecystitis
WSES Guidelines for the management of acute left sided colonic diverticulitis in the emergency setting

15

Mazuski, et al

2017

The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infections

Strongly recommended

16

Sartelli, et al

2017

Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference

Strongly recommended

17

Sartelli, et al

2017

The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections

Strongly recommended

18

Hirschﬁeld, et al

2017

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

Strongly recommended

Strongly recommended
Not recommended
Can be recommended
Strongly recommended
Strongly recommended
Not recommended
Strongly recommended
Strongly recommended
Strongly recommended
Strongly recommended
Strongly recommended
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Such a grouping
carried out based on
the population of
normal flora of a
region. The pattern of
microorganism grew
in the media culture of
pus taken from
abdominal cavity
intraoperatively was as
follows. Data in dr.
Soetomo hospital
showed that out of 114
subjects, bacteriology
exams preceded on 65
subjects (57%) only
for unknown reason,
and data in dr. Cipto
Mangunkusumo
showed that out of 74
isolates taken from 58
subjects (41.34%)
there were no
growth.16
The five mostly found
organisms in the
culture was
Escherichia coli
(35.41%), Klebsiella
pneumonia (13.44%),
others (9.84%)
Enterobacter cloaca
(9.34%), Proteus
mirabilis (8.69%).
Enterococcus faecalis
(7.87%),
Acinetobacter
baumannii (5.74%),
Staphylococcus
epidermidis (3.44%),
Pseudomonas
aeruginosa (3.44%),
Staphylococcus
haemolyticus (1.31%),
Klebsiella oxycata
(0.66%), and
Staphylococcus aureus
(0.66%) were also
reported (table 1).
Data obtained from
Hasan Sadikin
General Hospital were
not solely from pus,
but in combination
with sputum and
blood samples.
However, the data was
reported in a published
study of Asian
population.17
Data of bacterial
susceptibility to

antibiotic were obtained from three centers, i.e. RSCM, Soetomo
and Sardjito, and were found not different; whereas data from other
four were insufficient and unable to be analyzed furthers. In the
collection, the focused were on the most organisms found from pus
specimen of intraabdominal (see table 2 to 5).
Discussion
By definition it is clear that complicated intraabdominal infection is a
clinical entity, namely a syndrome which is not a clinical diagnosis
listed in the international classification of diseases.6 It was a new
insight (although, it wasn’t really a new one, since the entity realized
to be a focus as the paradigm of sepsis shifted after 1980s) and were
the focus of those who involved in the management, as the entity
offered a poor prognosis even though the new antibiotic generations
were used.7 The experts who were clinicians with a great concerns in
such a focus think that the syndrome should be treated strategically,
which is surgical and the antibiotic8,9 tried to developed guidelines
based on the highest evidence to have a better outcome in addition to
minimize or even to control irrational use of empiric antibiotic. But is
should be noted that it was not a kind of regulation to eradicate
variations.2
For this purpose, guideline of a high quality is required. A quality
CPGs rigorously developed evidence based guidelines minimize the
potential harms. But indeed, they have potential benefits and harms.10
Quality of guidelines as the confidence that the potential biases of
guideline development have been addressed adequately and that the
recommendations are both internally and externally valid, and are
feasible for practice,4,11 thus it should be evaluated. The assessment
includes judgments about the methods used for developing the
guidelines, the components of the final recommendations, and the
factors that are linked to their uptake.11
The use of AGREE II tools was based on recent systematic reviews
that a tool is an outstanding on CPGs appraising.12–14 Out of thirty–
three CPGs related to cIAIs, eighteen were selected and based on the
assessment, there were thirteen guidelines were ‘strong
recommended’, three were ‘can be recommended’ and other two
were ‘not recommended’. The assessment of this kind using a tool
that lead to a judgement of how to find out guidelines of the best
quality. The key point is the development process, but not the
recommendations.
Of these CPGs, there should be some to be chosen to be adopted.
Then, the option was to assess the updating. A quality of CPGs is
when it continuously updated. Regarding assessment of this update,
CheckUp can be used to evaluate the completeness of reporting in
updated guidelines and as a tool to inform guideline developers about
reporting requirements. Editors may request its completion from
guideline authors when submitting updated guidelines for
publication. Adherence to CheckUp will likely enhance the
comprehensiveness and transparency of clinical guideline updating
for the benefit of patients and the public, health care professionals,
and other relevant stakeholders.3 But, as concluded by Vernooij et al,
there are currently no gold standards for guideline updating
methodology. Nonetheless, updating is key to ensuring trustworthy,
implementable, and clinically relevant recommendations. Current
guideline evaluation tools or guideline method resources (e.g.,
AGREE II, Grading of Recommendations Assessment,
Development, and Evaluation (GRADE), IOM Standards, and the
like) are not simply transferable to the conceptual requirements of an
updated guideline. CheckUp addresses the gap: it has been supported
by our study participants and is a resource that complements (rather
58

than competes with) the other high-quality tools available in the
guideline enterprise.3
This appraisal using assessment tools formulated by AGREE offered
a lot of critical insight to a CPGs to be implemented or adopted since
it deals with the process of how a recommendation is formulated, not
to the statement of recommendation itself. Thus, it might have
described of why a CPGs encountering barriers in the
implementation.4,11,15 In contrast, it supposed to be some critical
points for the developers.
Out of eighteen CPGs, there were eleven CPGs focused on the
management comprehensively starting with population at risk (or
high risk), diagnostic, surgical and antibiotic management; whereas
the rest were focused solely on antibiotics. This should be noticed,
that antibiotic is an integral part of management, but not the only. It
was seen that those with comprehensive measurement were
categorized as strong recommended, that might be benefit to those
dealing with cIAIs; and certainly, for the patient safety. It referred to
be required in the clinical practice.

11.

12.

13.

14.

15.
16.

Conclusion
Perforated appendicitis, perforated gastric and duodenal ulcer, small
bowel perforation, large bowel perforation, and postoperative in
sequent are the main causal of cIAI in Indonesia. The epidemiology
predominated by Gram negative, particularly Escherichia coli and
Klebsiella pneumonia.

17.

18.

19.
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